《World Journal of Gastrointestinal Pharmacology and Therapeutics》

作品数：363被引量：910H指数：14
导出分析报告
《World Journal of Gastrointestinal Pharmacology and Therapeutics》
主办单位：百世登出版集团有限公司
最新期次：2025年1期更多>>
发文主题：PHARMACOLOGYEDITORIALCITATIONULCERATIVE_COLITISINSTRUCTIONS更多>>
发文领域：医药卫生一般工业技术哲学宗教更多>>
发文基金：国家自然科学基金World Health Organization更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Comprehensive review of Clostridium difficile infection:Epidemiology,diagnosis,prevention,and treatment
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2025年第1期1-9,共9页Xue Wang Wen-Yue Wang Xue-Lu Yu Jing-Wen Chen Ji-Shun Yang Ming-Ke Wang 
In recent years,nosocomial infections caused by Clostridium difficile(C.difficile)have risen,becoming a leading cause of hospital-acquired diarrhea.The global prevalence of C.difficile infection(CDI)varies across regi...
关键词：Clostridium difficile Pseudomembranous colitis Public health safety EPIDEMIOLOGY PREVENTION Diagnosis and treatment 
Insight into global burden of gastroesophageal reflux disease:Understanding its reach and impact
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2025年第1期10-24,共15页Nilanka Wickramasinghe Niranga Manjuri Devanarayana 
The exact worldwide prevalence of gastroesophageal reflux disease(GERD)re-mains uncertain,despite its recognition as a common condition.This conundrum arises primarily from the lack of a standardized definition for GE...
关键词：Gastroesophageal reflux disease Global PREVALENCE HEARTBURN SCREENING 
Rebamipide in gastric mucosal protection and healing:An Asian perspective
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2025年第1期25-36,共12页Manish Kak 
This review emphasizes the exemplary safety and efficacy of rebamipide in the treatment of gastric ulcers and other mucosa-related disorders,positioning it as a viable candidate for inclusion in treatment guidelines a...
关键词：REBAMIPIDE Peptic ulcer Gastroesophageal reflux disease Mucosal protection TREATMENT 
Real-world-evidence,prospective-observational study to evaluate safety and effectiveness of rabeprazole dual-delayed-release capsules in patients with gastroesophageal reflux disease
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2025年第1期37-45,共9页Parimal Lawate Virender Chauhan Lingampalli Rajendra Prasad Abhimanrao Pawar Atul G Puranik Alok Bansal Abhiram Koganti Ashok Jaiswal Pranali Puradkar Kunal Jhaveri 
BACKGROUND Abnormal gastric acid reflux into the esophagus causes symptoms of gastroeso-phageal reflux disease(GERD)such as heartburn and regurgitation and also leads to mucosal damage.This damage can further lead to ...
关键词：Gastroesophageal reflux disease HEARTBURN Acid reflux RABEPRAZOLE Dual delayed-release 
Insights of gut-liver axis in hepatic diseases:Mechanisms,clinical implications,and therapeutic potentials
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2024年第6期1-17,共17页Naveen Jeyaraman Madhan Jeyaraman Tejaswin Mariappan Sathish Muthu Swaminathan Ramasubramanian Shilpa Sharma Gabriel Silva Santos Lucas Furtado da Fonseca JoséFábio Lana 
With the rising prevalence of chronic liver diseases worldwide,there exists a need to diversify our artillery to incorporate a plethora of diagnostic and therapeutic methods to combat this disease.Currently,the most c...
关键词：Gut-liver axis DYSBIOSIS Liver disease PROBIOTICS Fecal microbiota transplantation Precision medicine 
Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2024年第6期18-27,共10页Mohamed Abdel-Samiee Essam Salah Ibrahim Mohamed Kohla Eman Abdelsameea Mohsen Salama 
The global incidence of nonalcoholic fatty liver disease(NAFLD)is escalating considerably.NAFLD covers a range of liver conditions from simple steatosis to the more severe form known as nonalcoholic steatohepatitis,wh...
关键词：Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis MYOFIBROBLASTS FIBROSIS Antifibrotic pharmacotherapy Nonalcoholic fatty liver disease treatment strategies Emerging treatments for nonalcoholic steatohepatitis 
Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2024年第6期28-38,共11页Madhav Changela Sagar Pandey Janak Bahirwani Nishit Patel Maulik Kaneriya Sanket D Basida Anish Shah Rahul Thakur Krishna Bodrya Suruchi Jai Kumar Ahuja Yecheskel Schneider 
BACKGROUND Inflammatory bowel disease(IBD),with its rising prevalence rates is associated with an increased risk of cardiovascular and thromboembolic events.Antiplatelets and/or anticoagulants agents are often prescri...
关键词：Inflammatory bowel disease ANTICOAGULATION Antiplatelet therapy Healthcare utilization MORTALITY 
Predicting full-thickness necrosis in adult acute corrosive ingestion injuries in a sub-Saharan African setting
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2024年第6期39-50,共12页Matthias Frank Scriba Eduard Jonas Galya Eileen Chinnery 
BACKGROUND Corrosive ingestion remains an important global pathology with high morbidity and mortality.Data on the acute management of adult corrosive injuries from sub-Saharan Africa is scarce,with international inve...
关键词：Corrosive injuries Caustic injuries ADULT Predicting necrosis Endoscopy predictive performance CT predictive performance Short-term survival 
Inflammatory bowel disease in Pakistan:Low prevalence or underdiagnosis?
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2024年第6期51-53,共3页Zubia Zaman Zain Majid 
Inflammatory bowel disease(IBD)has a low prevalence in the Global South,including Pakistan.While genetics and gut flora,influenced by diet and the environment,can contribute to this,we are exploring the possibility of...
关键词：Inflammatory bowel disease Crohn’s disease Ulcerative colitis Pakistan Third world country 
Therapeutics involved in managing initial and recurrent Clostridium difficile infection:An updated literature review
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2024年第5期1-14,共14页Vignesh K Nagesh Hadrian Hoang-Vu Tran Daniel Elias Izage Kianifar Aguilar Tanni Sethi AiswaryaMenon Charlene Mansour Florchi Furman Kylie Tsotsos Talia Subar Auda Auda Aman Sidiqui JevonLamar Nikita Wadhwani Shraboni Dey Abraham Lo Adam Atoot Simcha Weissman Humberto Sifuentes Ayrton I Bangolo 
Clostridium difficile infection(CDI)has been increasing due to the effect of recurrent hospitalizations.The use of antibiotics has been shown to alter the gut microbiome and lead to CDIs.The treatment is limited to th...
关键词：Clostridium difficile ANTIBIOTICS VANCOMYCIN Fidaxomicin Prevention Bezlotoxumab Fecal microbiota transplant 
全选清除导出
共37页<12345678910>
检索报告 对象比较 聚类工具 使用帮助 返回顶部